|
|
 |
|
Viewing report
|
|
|
|
Daiichi Sankyo Co., Ltd: PharmaVitae Profile
Datamonitor, Dec 2010, Pages: 59
Introduction
This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
- Gain insight into Daiichi Sankyo's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Highlights
- Strategic insight into the prospects for Daiichi Sankyo over the next six years.
- Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
- Benchmark Daiichi Sankyo's performance against key rivals in the prescription pharmaceutical sector
- Identify the key growth drivers that will propel Daiichi Sankyo to the second biggest company in the Japan pharma peer set in terms of Rx sales
- Look at the strategies being employed by Daiichi as it looks to outperform its Japanese peers
|
|
|
|
